• 2022
  Bridel S, Bouchez V, Brancotte B, Hauck S, Armatys N, Landier A, Mühle E, Guillot S, Toubiana J, Maiden MCJ, Jolley KA, Brisse S, , A comprehensive resource for Bordetella genomic epidemiology and biodiversity studies., Nat Commun 2022 Jul; 13(1): 3807.
• 2022
  Lefrancq N, Bouchez V, Fernandes N, Barkoff AM, Bosch T, Dalby T, Åkerlund T, Darenberg J, Fabianova K, Vestrheim DF, Fry NK, González-López JJ, Gullsby K, Habington A, He Q, Litt D, Martini H, Piérard D, Stefanelli P, Stegger M, Zavadilova J, Armatys N, Landier A, Guillot S, Hong SL, Lemey P, Parkhill J, Toubiana J, Cauchemez S, Salje H, Brisse S, , Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis., Sci Transl Med 2022 Apr; 14(642): eabn3253.
• 2019
  Badell E, Guillot S, Tulliez M, Pascal M, Panunzi LG, Rose S, Litt D, Fry NK, Brisse S, Improved quadruplex real-time PCR assay for the diagnosis of diphtheria, J. Med. Microbiol. 2019 Sep;.
• 2019
  Toubiana J, Azarnoush S, Bouchez V, Landier A, Guillot S, Matczak S, Bonacorsi S, Brisse S, , Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics., Open Forum Infect Dis 2019 Apr; 6(4): ofz122.
• 2019
  Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim D, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, He Q, Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015., Euro Surveill 2019 Feb; 24(7): .
• 2018
  Ben Fraj I, Kechrid A, Guillot S, Bouchez V, Brisse S, Guiso N, Smaoui H, Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016, J. Med. Microbiol. 2019 Feb;68(2):241-247.
• 2018
  Bouchez V, Baines SL, Guillot S, Brisse S, Complete Genome Sequences of Bordetella pertussis Clinical Isolate FR5810 and Reference Strain Tohama from Combined Oxford Nanopore and Illumina Sequencing, Microbiol Resour Announc 2018 Nov;7(19).
• 2018
  Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim DF, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, Auranen K, He Q, Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015, J. Clin. Microbiol. 2018 05;56(5).
• 2017
  Guiso N, Levy C, Romain O, Guillot S, Werner A, Rondeau MC, Béchet S, Cohen R, Whooping cough surveillance in France in pediatric private practice in 2006-2015, Vaccine 2017 10;35(45):6083-6088.
• 2016
  Guillot S, Guiso N, Follow-Up of External Quality Controls for PCR-Based Diagnosis of Whooping Cough in a Hospital Laboratory Network (Renacoq) and in Other Hospital and Private Laboratories in France, J. Clin. Microbiol. 2016 Aug;54(8):2169-71.
• 2015
  Tubiana S, Belchior E, Guillot S, Guiso N, Lévy-Bruhl D,, Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network: Results from 17 Years’ Experience, 1996-2012, France, Pediatr. Infect. Dis. J. 2015 Aug;34(8):814-20.
• 2013
  Nguyen LB, Epelboin L, Gabarre J, Lecso M, Guillot S, Bricaire F, Caumes E, Guiso N, Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab, Emerging Infect. Dis. 2013 Oct;19(10):1703-5.
• 2012
  Guillot S, Descours G, Gillet Y, Etienne J, Floret D, Guiso N, Macrolide-resistant Bordetella pertussis infection in newborn girl, France, Emerging Infect. Dis. 2012 Jun;18(6):966-8.
• 2011
  Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guillot S, Guiso N, Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis, J. Clin. Microbiol. 2011 Dec;49(12):4347-8.
• 2011
  Le Coustumier A, Njamkepo E, Cattoir V, Guillot S, Guiso N, Bordetella petrii infection with long-lasting persistence in human, Emerging Infect. Dis. 2011 Apr;17(4):612-8.
• 2008
  Riquet FB, Blanchard C, Jegouic S, Balanant J, Guillot S, Vibet MA, Rakoto-Andrianarivelo M, Delpeyroux F, Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus, J. Virol. 2008 Sep;82(17):8927-32.
• 2007
  Gouandjika-Vasilache I, Burns CC, Gumede N, Guillot S, Ménard D, Dosseh A, Akoua-Koffi C, Pallansch MA, Kew OM, Delpeyroux F, Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay, Arch. Virol. 2008;153(3):409-16.
• 2007
  Rakoto-Andrianarivelo M, Guillot S, Iber J, Balanant J, Blondel B, Riquet F, Martin J, Kew O, Randriamanalina B, Razafinimpiasa L, Rousset D, Delpeyroux F, Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar, PLoS Pathog. 2007 Dec;3(12):e191.
• 2005
  Suspène R, Henry M, Guillot S, Wain-Hobson S, Vartanian JP, Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR, J. Gen. Virol. 2005 Jan;86(Pt 1):125-9.
• 2005
  Rakoto-Andrianarivelo M, Rousset D, Razafindratsimandresy R, Chevaliez S, Guillot S, Balanant J, Delpeyroux F, High frequency of human enterovirus species C circulation in Madagascar, J. Clin. Microbiol. 2005 Jan;43(1):242-9.
• 2003
  Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, Mauclère P, Delpeyroux F, Recombinant vaccine-derived poliovirus in Madagascar, Emerging Infect. Dis. 2003 Jul;9(7):885-7.
• 2002
  Oprisan G, Combiescu M, Guillot S, Caro V, Combiescu A, Delpeyroux F, Crainic R, Natural genetic recombination between co-circulating heterotypic enteroviruses, J. Gen. Virol. 2002 Sep;83(Pt 9):2193-200.